Pacira Pharmaceuticals(DE:82P)
€32.400.00 (0.00%)
DE:82P
Pacira Pharmaceuticals earnings date
€32.40
At close:0.00 (0.00%)
Pacira Pharmaceuticals (82P) Q2 2022 Earnings Report
0 Followers
DE:82P Q2 2022 EPS Results
- Actual EPS
- EUR 0.46
- Consensus EPS
- EUR 0.76
- Beat/Miss
- Missed by -EUR 0.31
- One Year Ago EPS
- EUR 0.69
DE:82P Q2 2022 Revenue Results
- Actual Revenue
- EUR 151.68M
- Expected Revenue
- EUR 152.79M
- Beat/Miss
- Missed by -EUR 1.10M
- YoY Revenue Growth
- +24.94%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/03/2022
- Time
- Before Open
- Conference Call
- Wednesday, August 3, 2022
DE:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.51 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.670.62 | 0.63 | -0.29% (-0.00) | |
| Aug 04, 2026 | 2026 (Q2) | 0.580.65 | 0.66 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.490.54 | 0.56 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.51 | 0.81 | -37.36% (-0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.610.63 | 0.71 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.640.66 | 0.8 | -16.85% (-0.13) | |
| May 08, 2025 | 2025 (Q1) | 0.530.56 | 0.56 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.750.81 | 0.8 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.630.71 | 0.64 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

